SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-17-002849
Filing Date
2017-03-24
Accepted
2017-03-24 19:47:26
Documents
1
Period of Report
2015-05-30

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 11458
  Complete submission text file 0001493152-17-002849.txt   13051
Mailing Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210
Business Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210 (310) 279-5152
PetLife Pharmaceuticals, Inc. (Issuer) CIK: 0001354591 (see all company filings)

IRS No.: 331133537 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2860 Industrial Organic Chemicals

Mailing Address 62 HOOK AVENUE TORONTO A6 M6P IT4
Business Address
Campbell Vyvyan (Reporting) CIK: 0001700395 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52445 | Film No.: 17713914